Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.41 and traded as high as $0.66. Mesoblast shares last traded at $0.66, with a volume of 244,310 shares traded.
Mesoblast Stock Performance
The stock has a 50 day simple moving average of $0.75 and a two-hundred day simple moving average of $0.41.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Read More
- Five stocks we like better than Mesoblast
- Top Stocks Investing in 5G Technology
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Progress Software Stock Back in the Green After Beating Forecasts
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.